Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4051)
All Articles published online
|
Nov 28, 2007 (publication date) through Apr 22, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| El Haj M, Ya'acov AB, Lalazar G, Ilan Y. Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis. World J Gastroenterol 2007; 13(44): 5799-5804 [PMID: 17990345 DOI: 10.3748/wjg.v13.i44.5799] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | El Haj M, Ya'acov AB, Lalazar G, Ilan Y. Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis. World J Gastroenterol 2007; 13(44): 5799-5804 [PMID: 17990345 DOI: 10.3748/wjg.v13.i44.5799] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i44/5799.htm |
| Number | Citing Articles |
| 1 |
Ying Liu, Qiang Shu, Lifen Gao, Nan Hou, Di Zhao, Xiao Liu, Xiaoning Zhang, Liyun Xu, Xuetian Yue, Faliang Zhu, Chun Guo, Xiaohong Liang, Chunhong Ma. Increased Tim-3 expression on peripheral lymphocytes from patients with rheumatoid arthritis negatively correlates with disease activity. Clinical Immunology 2010; 137(2): 288 doi: 10.1016/j.clim.2010.07.012
|
| 2 |
Yaron Ilan, Ami Ben Ya'acov, Yehudit Shabbat, Svetlana Gingis-Velitski, Einat Almon, Yoseph Shaaltiel. Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis. World Journal of Gastroenterology 2016; 22(39): 8760-8769 doi: 10.3748/wjg.v22.i39.8760
|
| 3 |
Tomer Adar, Ravi Shankar Lankalapalli, Robert Bittman, Yaron Ilan. The assembly of glycosphingolipid determines their immunomodulatory effect: A novel method for structure-based design of immunotherapy. Cellular Immunology 2020; 355: 104157 doi: 10.1016/j.cellimm.2020.104157
|
| 4 |
Yaron Ilan. β-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01143
|
| 5 |
Einat Almon, Tawfik Khoury, Ariel Drori, Svetlana Gingis-Velitski, Sari Alon, Raul Chertkoff, Mordechai Mushkat, Yoseph Shaaltiel, Yaron Ilan. An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: Results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy. Journal of Immunological Methods 2017; 446: 21 doi: 10.1016/j.jim.2017.03.023
|
| 6 |
Meir Mizrahi, Tomer Adar, Gadi Lalazar, Dean Nachman, Madi El Haj, Ami Ben Ya’acov, Yoav Lichtenstein, Yehudit Shabat, Dimitri Kanovich, Lida Zolotarov, Yaron Ilan. Glycosphingolipids Prevent APAP and HMG-CoA Reductase Inhibitors-mediated Liver Damage: A Novel Method for “Safer Drug” Formulation that Prevents Drug-induced Liver Injury. Journal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00071
|
| 7 |
Tahel Ilan-Ber, Yaron Ilan. The role of microtubules in the immune system and as potential targets for gut-based immunotherapy. Molecular Immunology 2019; 111: 73 doi: 10.1016/j.molimm.2019.04.014
|
| 8 |
Jana Šímová, Marie Indrová, Jana Bieblová, Romana Mikyšková, Jan Bubeník, Milan Reiniš. Therapy for minimal residual tumor disease: β‐Galactosylceramide inhibits the growth of recurrent HPV16‐associated neoplasms after surgery and chemotherapy. International Journal of Cancer 2010; 126(12): 2997 doi: 10.1002/ijc.24887
|
| 9 |
Yuval Ishay, Ari Zimran, Jeffrey Szer, Tama Dinur, Yaron Ilan, David Arkadir. Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug development. Blood Cells, Molecules, and Diseases 2018; 68: 117 doi: 10.1016/j.bcmd.2016.10.028
|
| 10 |
Tawfik Khoury, Yuval Ishay, Devorah Rotnemer-Golinkin, Lidya Zolotarovya, David Arkadir, Ari Zimran, Yaron Ilan. A synergistic effect of Ambroxol and Beta-Glucosylceramide in alleviating immune-mediated hepatitis: A novel immunomodulatory non-immunosuppressive formulation for treatment of immune-mediated disorders. Biomedicine & Pharmacotherapy 2020; 132: 110890 doi: 10.1016/j.biopha.2020.110890
|
| 11 |
Chansu Lee, Sung Noh Hong, Young-Ho Kim. A glycolipid adjuvant, 7DW8-5, provides a protective effect against colonic inflammation in mice by the recruitment of CD1d-restricted natural killer T cells. Intestinal Research 2020; 18(4): 402 doi: 10.5217/ir.2019.00132
|
| 12 |
Eran Israeli, Ehud Zigmond, Gadi Lalazar, Athalia Klein, Nilla Hemed, Eran Goldin, Yaron Ilan. Oral mixture of autologous colon-extracted proteins for the Crohn’s disease: A double-blind trial. World Journal of Gastroenterology 2015; 21(18): 5685-5694 doi: 10.3748/wjg.v21.i18.5685
|
| 13 |
Eran Israeli, Yaron Ilan. Review: Oral administration of Alequel, a mixture of autologous colon-extracted proteins for the treatment of Crohn’s disease. Therapeutic Advances in Gastroenterology 2010; 3(1): 23 doi: 10.1177/1756283X09351733
|
| 14 |
Janice A. Layhadi, Liliana Cifuentes Gutierrez, Sean T. Keane, William Fulton, Nichell A. Samson, Lily Y. D. Wu, Paulina Filipaviciute, Prista Hikmawati, Oleksandra Fedina, Ana Jimenez‐Gil, Stephen R. Durham, Guy Scadding, Guy Tropper, Louis‐Philippe Vézina, Patrick Colin, Ronald van Ree, Mohamed H. Shamji. Fel d 1‐Expressing Plant‐Derived Bioparticle: A Novel Treatment for Cat Allergy. Allergy 2026; doi: 10.1111/all.70280
|